Join our Community
Support ToI and remove all ads
Learn more

ISRAEL AT WAR - DAY 431

Pfizer

CytoReason co-founders from right to left: David Harel, CEO, Professor Shai Shen-Orr, chief scientist, Elina Starosvetsky, VP biology, and Renaud Gaujoux, principal scientist and data science architect. (Fabian Koldorff)
July 17, 2024, 9:50 pm
Backed by Nvidia and Pfizer, Israeli AI medical startup raises $80m in fresh capital
Tel Aviv-based CytoReason, which uses machine learning to build computational models of human diseases to speed up treatment discoveries, plans to open a US office later this year
By Sharon Wrobel
Staff Sgt. (res.) Hanan Drori, 26, who died from a fungal infection after being seriously injured in Gaza, February 7, 2024. (Israel Defense Forces)
February 7, 2024, 1:03 pm
Staff Sgt. (res.) Hanan Drori, 26, dies of fungal infection after Gaza injury
Doctors and family sourced experimental treatments for infection, but to no avail; ground op toll rises to 227
By ToI Staff
Illustration: Antibodies attacking contagious virus cells (wildpixel; iStock by Getty Images)
February 28, 2023, 5:21 pm
Israel lab backed by pharma giants mints startup for computer-designed antibodies
AION Labs, a consortium formed by Pfizer, Merck, AstraZeneca, Teva and others, sets up company to build a computational platform to design live-saving antibodies from scratch
By Sharon Wrobel
Illustrative image: A medical worker prepares a vial of the Pfizer coronavirus vaccine at Clalit Health Service's center in the Cinema City complex in Jerusalem, on Wednesday, Sept. 22, 2021. (AP Photo/Maya Alleruzzo)
November 10, 2022, 4:44 pm
4th COVID shot boosts antibodies for 13 weeks, Israeli study finds
Research shows defense against infection fades by 15 weeks, but protection against serious illness may be longer, according to researchers at Sheba Medical Center
By Nathan Jeffay
In this May 19, 2021, photo, a licensed practical nurse draws a Moderna COVID-19 vaccine into a syringe at a mass vaccination clinic at Gillette Stadium in Foxborough, Massachusetts. (AP Photo/Steven Senne)
October 7, 2022, 11:46 am
4th shots of Pfizer, Moderna vaccines provide near equal protection — Israeli study
Sheba-led research team says that 6 months after boosters, ‘antibody levels and cumulative vaccine efficacy do not differ between the two vaccines’
By Nathan Jeffay
OMEC.AI co-founders Ori Shachar, left, and Amir Harel, right. (Elad Malka)
September 28, 2022, 2:08 pm
Israeli innovation lab backed by pharmaceutical, biotech giants mints 1st AI startup
AION Labs, a Rehovot-based consortium formed by Pfizer, Merck, AstraZeneca, Teva and others, sets up company that will help drug firms improve chances of success in clinical trials
By Ricky Ben-David
A woman walks in front of Pfizer's headquarters in Manhattan, November 2020. (Massimo Giachetti via iStock by Getty Images)
September 20, 2022, 3:00 pm
Pfizer backs Israel’s CytoReason, inks new research deal for AI drug development
US pharmaceutical giant to make $20m equity investment, part of larger agreement to license tech and collaborate on R&D
By Ricky Ben-David
Illustrative image: an Israeli woman receives a coronavirus vaccine at the Hadassah Medical Center, in Jerusalem, on January 6, 2022. (Olivier Fitoussi/Flash90)
September 15, 2022, 6:46 am
Israelis to start getting new variant-tailored shots by end of month — COVID czar
Second-generation vaccines being distributed to healthcare providers, as scientific community waits expectantly to see how much they help
By Nathan Jeffay
File: A vial of Moderna COVID-19 vaccine, on a table at an inoculation station next to Jackson State University in Jackson, Mississippi, on July 19, 2022. (AP Photo/ Rogelio V. Solis)
August 26, 2022, 5:20 pm
Moderna sues Pfizer, BioNTech over patents behind COVID vaccine
Massachusetts-based firm accuses rival and its partner of copyright infringement, filing suit in both US and German courts
By Tom Murphy
Albert Bourla, Chief Executive Officer, Pfizer, speaks at a Press Conference on Pfizer and Partners Announce Accord for a Healthier World at the 51st annual meeting of the World Economic Forum, WEF, in Davos, Switzerland, May 25, 2022. (Gian Ehrenzeller/Keystone via AP)
June 27, 2022, 4:18 pm
Pfizer CEO to Israeli TV: Omicron shots ready for use as soon as FDA approves
Albert Bourla insists his company’s original vaccine is safe for children as young as 6 months, says he’s aiming to create vaccine that offers yearlong protection
By ToI Staff
A syringe is prepared with the Pfizer COVID-19 vaccine at a vaccination clinic at the Keystone First Wellness Center in Chester, Pennsylvania, December 15, 2021. (AP Photo/Matt Rourke, File)
June 25, 2022, 7:24 pm
Pfizer says tweaked COVID vaccine boosts Omicron protection
Pharma firm announces it has ‘two very strong’ candidates against the coronavirus variant, as US regulators set to weigh whether to offer updated boosters
By LAURAN NEERGAARD
In this file photo the Pfizer logo is seen at the Pfizer Inc. headquarters on December 9, 2020 in New York City. (Angela Weiss/AFP)
May 3, 2022, 10:00 pm
Pfizer sees strong demand for COVID pill as profits surge
CEO Albert Bourla says Paxlovid ‘remains one of the best tools we have’ to fight coronavirus, US pharma firm working to develop booster that provides immunity for a year
By John BIERS
In this February 2, 2021, file photo, students wear masks as they work in a fourth-grade classroom, at Elk Ridge Elementary School in Buckley, Washington. (AP Photo/Ted S. Warren, File)
April 14, 2022, 4:00 pm
Pfizer seeking to expand COVID booster shots for healthy elementary school-age kids
Company says new data shows healthy 5 to 11-year-olds could benefit from another kid-sized shot; US has yet to allow vaccinations for children under 5
By lauren neergard
A health worker prepares to give a dose of the COVID-19 vaccine at a Clalit Health Services center in Katzrin, Golan Heights, January 9, 2022. (Michael Giladi/Flash90)
February 16, 2022, 9:51 pm
In first test outside US, Israeli hospital to trial Omicron-specific Pfizer vaccine
As part of new research, Sheba Medical Center will administer 200 doses of a new shot designed to have increased effectiveness against the variant
By Nathan Jeffay
The Pfizer building on East 42nd Street in New York City. (ChainGangPictures via iStock by Getty Images)
February 10, 2022, 5:15 pm
Pfizer extends cooperation deal with Israeli AI drug development firm CytoReason
Tel Aviv-based startup uses machine learning to build computational models of human diseases to speed up treatment discoveries
By Ricky Ben-David
Load More
Sign in or Register
Please use the following structure: example@domain.com
Or Continue with
By registering you agree to the terms and conditions
Register to continue
Or Continue with
Log in to continue
Sign in or Register
I forgot my password / Send me a sign in link
Or Continue with
check your email
Check your email
We sent an email to you at .
It has a link that will sign you in.
Never miss breaking news on Israel
Get notifications to stay updated
You're subscribed
image
Register for free
and continue reading
Registering also lets you comment on articles and helps us improve your experience. It takes just a few seconds.
Already registered? Enter your email to sign in.
Please use the following structure: example@domain.com
Or Continue with
By registering you agree to the terms and conditions. Once registered, you’ll receive our Daily Edition email for free.
Register to continue
Or Continue with
Log in to continue
Sign in or Register
I forgot my password / Send me a sign in link
Or Continue with
check your email
Check your email
We sent an email to you at .
It has a link that will sign you in.